Presentations

 

1.       Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularization  (CNV). Newsom RSB, Mcallister J, Saeed M, McHugh D. American Academy of Ophthalmology, Orlando, 1999.

  

2. Transpupillary thermotherapy (TTT) of classic and occult choroidal neovascularization due to age related macular degeneration; results at 29 months. Newsom RSB, McAlister JC, Saeed M, Khaled El-Ghonemy, McHugh JDA. Club Jules Gonin 2002.

 

3. Intravitreal Bevacizumab (Avastin) for the Treatment of Neovascular Age-Related Macular Degeneration: Results From 118 Cases. R.S. Newsom, K.C. Madhusudhana, S.R. Hannan1, C.P. R. Williams, S.Goverdhan, C.Rennie, A.J. Lotery, A.J. Luff. ARVO 2007

 

4. Photocoagulation for Diabetic Macular Edema? E.Estabrook1, K.Madhusudhana2, S.Hannan2, R.Newsom2. ARVO 2007

 

5. The Effects of Perfluorodecalin on the Visual Outcomes of Acute Retinal Detachment Repair. I.Y. Yeung, R.S. Newsom, H.K. Kang. ARVO 2007

 

6. Combined Phacovitrectomy for Macular Hole: Long-Term Results S.Rogers, K.C. Madhusudhana, K.H. Kang, A.Luff, C.Canning, R.Newsom. ARVO 2007

 

7. Pattern Dystrophy: A Functional and Morphological Study S.R. Hannan1, K.C. Madhusudhana1, F.Shawkat1, R.S. B. Newsom1, A.J. Lotery. ARVO 2007

 

8. Effect of Intravitreal Bevacizumab (Avastin) on the Size of Lesion and Area of Leakage in Neovascular Age-Related Macular Degeneration K.C. Madhusudhana, S.R. Hannan, A.J. Lotery, A.J. Luff, R.S. B. Newsom. ARVO 2007

 

9. The Influence of Body Mass Index on the Visual Progression of Diabetic Patients Treated for Clinically Significant Macular Oedema. D.J. Mordant, N.Sinclair, A.Clover, R.S. V. Newsom. ARVO 2006.

 

10.    Effects of Intravitreal Triamcinolone on the Rate of Visual Recovery After Epiretinal Membrane Surgery. H.K. Kang, C.P. R. Williams, R.Newsom, A.Luff, C.Canning. ARVO 2006.

 

11.    Risk of Choroidal Neovascular Membrane (CNV) Following Cataract Surgery. S.R. Hannan1, K.C. Madhusudhana1, R.S. B. Newsom1, A.J. Lotery2. ARVO 2006.

 

12.    Severe visual loss  following silicone oil removal. Newsom RSB, Johnston R, Sullivan PM, Aylward GW, Gregor ZJ. Topics: 562  ARVO 2001.

 

13.    Chromatic discrimination threshold and achromatic contrast sensitivity in patients with CMV retinitis.  Ong G, Newsom RSB, Jackson T, O'Moore E, Fisher M, Casswell AG. Topics: 503 107 149 ARVO 1998.

 

14.    Retinal microvascular autoregulation demonstrated by tyramine induced hypertension in normal volunteers. Rassam SMB, Patel V, Newsom RSB, Kohner EM. ARVO, 1991.

15.    Automated retinal vessel measurements. Newsom RSB, Sullivan P, Jagoe R, Rassam SMB, Kohner EM. ARVO 1991.

  

16.    Risk of Choroidal Neovascular Membrane (CNV) Following Cataract Surgery. S.R. Hannan1, K.C. Madhusudhana1, R.S. B. Newsom1, A.J. Lotery2 2006.

 

17.    Effect of Acrovisc on corneal endothelium, a case controlled study. Roberts C, Newsom RSB, Newton J, Lees P, Canning CR. Oxford Congress of Ophthalmology 2001.

 

18.    Transpupillary thermotherapy for the treatment of occult choroidal neovascularization. Newsom RSB, Mcallister J, Saeed M, McHugh D. Oxford Congress of Ophthalmology 2000.

 

19.    Application of digital image compression to diabetic retinopathy screening. Newsom RSB, Costen M, Luff AJ, Clover A, Canning CR. Oxford Congress of Ophthalmology 2000.

 

20.    Screening for CMV retinitis using chromatic threshold discrimination. Newsom RSB, Ong G, Jackson T, Fisher M, Casswell AG. Oxford Congress Ophthalmology 1998.

 

21.    Cystoid macular oedema in patients with AIDS and CMV retinitis on highly active antiretrovial therapy. Newsom RSB, O'Moore E,  Fisher M, Casswell AG. Retinal Satellite; Oxford Ophthalmological Congress  July 1997.

 

22.    Can Optical Coherence Tomography Predict the Outcome of Laser Photocoagulation for Clinically Significant Macular Oedema?  E Estabrook, K C Madhusudhana, S R Hannan,R S B Newsom

 

23.    Intravitreal Bevacizumab (Avastin) for the Treatment of Neovascular Age-related Macular Degeneration: Results from 118 Cases K C Madhusudhana, S R Hannan, C P R Williams, SV Goverdhan, A J Lotery, A J Luff, R S B Newsom Southampton Eye Unit, Southampton

 

24.    Does screening improve the outcome of patients with diabetic maculopathy. Sinclair N, Booth A, Clover A, Newsom RSB. Royal College of Ophthalmology 2003

 

25.    Audit of Local anaesthesia for vitreo-retinal surgery. Knight H, Newsom RSB, Canning CR, Luff AJ, Wainwright AC.  Royal College of Ophthalmology 2001.

 

26.    Effect of video display properties and image compression on grading of diabetic retinopathy Costen MTJ, Newsom RSB, Parkin B, Marsh C, Luff AJ, Canning CR. Royal College of Ophthalmology 2001.

 

27.    UK survey of local anaesthesia for VR surgery. Newsom RSB, Canning CR, Luff AJ. Royal College of Ophthalmology 2001.

 

28.    Entonox reduces pain during pan retinal photocoagularion. Cook  HL, Newsom RSB, James D, ffytche TJ. Royal College of Ophthalmology 2001.

 

29.    Clinical evaluation of local contrast enhancement for fluorescein angiography. Newsom RSB, Sinthanayothin C, Boyce J, Williamson T, Casswell AG. Royal College of Ophthalmology 1999.

 

30.    PACE (Pneumato- cryo- explant) a new method for avoiding sub retinal fluid drainage in patients with rhegmatogenous retinal detachment. Saeed M, Newsom RSB, Mc Hugh D. Royal College of Ophthalmology Congress 1999.

 

31.    Digital colour and digital oral fluorescein angiography in the detection of diabetic retinopathy. Newsom RSB, Moate B, Casswell AG. Royal College of Ophthalmology Congress 1998.

 

32.    Three years follow up of mitomycin C for tabeculectomies. Davis A, Newsom RSB, Falcon MG. Royal College of Ophthalmologists Congress May 1996.

 

33.    The effect of pregnancy on diabetic retinal blood flow. Chen HC, Newsom RSB, Patel V, Rassam SMB, and Kohner EM. Royal college of Ophthalmology. April 1994.

  

34.    Screening for diabetic maculopathy with oral fluorescein angiography.  Newsom RSB, Moate B, Casswell AG.  British Diabetes Association, Harrogate 1998.

 

35.    Natural history of hard exudates. Cook HC, Newsom RSB, Long V, Stanford MS, Shilling JS. British Diabetes Association, Harrogate 1998.

 

 

36.    Chromatic and achromatic contrast sensitivity for screening for diabetic retinopathy. Ong G Newsom RSB, Moate B, Casswell AG. British Diabetes Association, Harrogate 1998.

 

37.    Retinal blood flow changes in pregnancy in diabetes. Kohner EM, Chen HC, Newsom RSB, Patel V, Casser J and Mather HM. British Diabetic Association Lancaster 1994.

 

38.    Factors effecting the progression of background retinopathy. Patel V, Newsom RSB, Clark P, Parfitt V, Kohner EM. British Diabetes Association, Harrogate 1992.

 

39.    Retinal haemodynamics in diabetic retinopathy. Rassam SMB, Patel V, Newsom RSB, Kohner EM. British Diabetes Association. Brighton, 1991.

 

40.    Retinal microvascular autoregulation to a controlled rise in systolic blood pressure. Patel V, Rassam SMB, Newsom RSB, Kohner EM. BDA, Brighton 1991. 

 

41.    Clinical haemodynamic risk factors in the pathogenesis of diabetic retinopathy. Patel V, Newsom RSB, Clark P, Parfitt V, Kohner EM. EASDEC. Turkey. September 1993.

 

42.    Clinical risk factors in the progression of background diabetic retinopathy. Patel V, Newsom RSB, Clark P, Parfitt V, Kohner EM. EASDEC. Baden Austria. Sept 1992.

 

43.    Effect of a tyramine induced rise in blood pressure on retinal blood flow in normal volunteers and diabetic patients. Rassam SMB, Patel V, Newsom RSB and Kohner EM. EASD. Dublin, 1991. 

 

44.    Why does my suture break. Nadieem Basin, Richard Newsom 2008.

 

45.    Avastin 12 month follow up data. S Khandadia and R Newsom. 2008.

 

46.    Vitreomacular traction in patients with AMD. Wintle and R Newsom 2008.

 

47.    Long term results of patients undergoing combined phacoemulsification and vitrectomy for macular holes. Kang K, Williams C, Luff AJ, Canning CR. 2006

 

48.    Use of perfluoredecalin in macular off retinal detachment. Newsom RSB, Williams C, Kang K, Luff AJ, Canning CR. 2006

 

49.    Visual outcome following IVTA enhancement for vitrectomy / peel procedure. Williams C, Kang K, Luff AJ, Canning CR, Newsom RSB. 2005.

 

50.    Sudden loss of vision following silicone oil removal. Newsom RSB, Johnston R, Sullivan PM, Aylward GW, Gregor Z. BEVRS 2000.

 

51.    Use of local anaesthesia for Vitreoretial surgery. Newsom RSB, Canning CR, Luff AJ. BEVRS 2000.

 

52.    Local anaesthesia for Vitreoretinal surgery, patient and surgeon tolerance survey.  Newsom RSB, Knight H, Canning CR, Luff AJ, Wainwright AC. BEVRS 2000.

 

53.    Effect of screening on the treatment of diabetic maculaopathy Newsom RSB 2004

 

54.    Kinetic anaesthesia for pan retinal photocoagulation. Wainwright C, Canning C, Newsom RSB 2004.

  

55.    The effect of Xalatan on C3F8 re-adsorption following macular hole surgery. Williams C, Newsom RSB, Canning CR, Luff AJ.  Royal Society of Medicine 2000.

 

56.    Digital enhancement of oral fluorescein angiograms. Newsom RSB, Sinthanayothin C, Boyce J, Williamson T, Casswell AG. Royal Society of Medicine 1998.

 

57.    Can hard exudates be followed in a diabetic-screening programme? Cook HC, Newsom RSB, Long V, Stanford MS, Shilling JS. Royal Society of Medicine 1998 (RSM Prize).

 

58.    Corneal opacification with peribulbar choristoma. Newsom RSB, Ayliffe W, Dhar-Munshi S, Kirkham N, Liu C. Royal Society of Medicine 1998.

 

59.    Contrast sensitivity in CMVR. Jackson T, Newsom RSB, Ong G, Fisher M, Casswell AG. Royal Society of Medicine 1998.

 

60.    Macular oedema in HIV+ patients with CMVR on protease inhibitors. Newsom RSB, O'Moore E, Fisher M, Casswell AG. Royal Society of Medicine 1997.

 

61.    Altitudinal defect with cerebral metastasis. Newsom RSB, Simcock P. Royal Society of Medicine, 1995.

 

62.    Bilateral CRAO from buried optic nerve head drusen. Newsom RSB, Trew DR, and Leonard TJK. Royal Society of Medicine June 1994

  

63.    Visual outcome of patients treated for newly diagnosed clinically significant macular oedema with focal argon laser photocoagulation. Sinclair N, Booth A, Clover C, Newsom RSB. Screening for diabetic retinopathy in Europe, 2005.

 

64.    Screening threshold test. for Sigh-Threatening diabetic retinopathy: Comparison of Fundus photography with automated colour contrast.  Ong GL, Ripley GR, Newsom RSB, Cooper M, Casswell, AG. Screening for diabetic retinopathy in Europe, 2005.

 

65.    Local anaesthesia for vitreoretinal surgery a survey of 1221 patients. Wainwright AC Newsom RSB, Canning CR. British Ophthalmic Anaesthetic Society 2000.

 

66.    Local anaesthesia for vitreo-retinal surgery; the patients view. Knight H, Newsom RSB, Canning CR, Luff AJ, Wainwright AC. British Ophthalmic Anaesthetic Society 2000.

 

67.    Ocular manifestations of CMV infection in AIDS patients in the era of HAART. O'Moore E, Newsom RSB, Fisher M, Casswell AG. British HIV Association. Oxford March 1998.

 

68.    Bilateral ophthalmic artery aneurysms presenting with progressive visual loss. Newsom RSB, Matthews TD, Bremner FD, Sanders MD. Medical Ophthalmological Society Feb 1998.

 

69.    Retinal haemodynamics following branch retinal artery occlusion.  Newsom RSB, Moate BJ, Casswell AG. Medical Ophthalmological Society Feb 1998.

 

70.    CMV Retinitis. Newsom RSB, Casswell AG. Southern Ophthalmic Society Prize Lecture. Portsmouth Nov. 1997.

 

71.    Central retinal vein occlusion; to treat or not to treat. Newsom RSB, Shilling J. Trends in Ophthalmology, St Thomas’ Hospital. Nov 1995.

 

72.    Palestine University Gaza – lecture series on Retinal and cataract Surgery. 2010.

73.    Update on retinal surgery, Nelson Mandela University, South Africa 2010.

74.    Transpupillary thermotherpy for Classic and Occult CNV. RSB Newsom. IIV International Vitreoretinal society. Parma 2002.

 

75.    Transpupillary thermotherpy for Classic and Occult CNV. RSB Newsom. PanHellinc Ophthalmolgical conference. Thessalonika 2002.

 

76.    OCT III PanHellinc Ophthalmolgical conference. Thessalonika 2002.

 

 

77.  Vitreolensectomy made easy, Newsom RB, Strauss G BEAVRS 2010

 

78. Comparison of 23g and 20g vitrectomy entry site breaks. Goss, Newsom R, Lochhead.

 

79. Central retinal vein Occulsion - update. Newsom RSB WR 2010.